"Our aim is to allow both research and commercial customers access to the highest quality DNA testing services for expanding applications in the food, pharma, and environmental fields." Medigenomix became part of the Eurofins group in 2001, and since 2005 Eurofins Medigenomix has represented the outsourcing partner of MWG for genomic services. Eurofins acquired an equity stake in MWG during 2004 and now owns some 85% of the company. "MWG has been fairly quiet with respect to major announcements over the last couple of years, but we have taken this time to develop the best strategy for maximizing the respective expertise of both MWG and Eurofins Medigenomix," Dr. Poddevin continued. "We believe Eurofins MWG is the perfect vehicle to promote both MWG and Eurofins Medigenomix' current and future portfolios, and offer clients the highest quality services and products."